Melanoma and the tumor microenvironment
- PMID: 18706274
- PMCID: PMC5662003
- DOI: 10.1007/s11912-008-0067-y
Melanoma and the tumor microenvironment
Abstract
Melanoma arises through the accrual of mutations in genes critical for proliferation and survival. Although melanoma had been traditionally conceptualized as a cell-autonomous event, increasing evidence supports the notion that these tumors are not isolated entities but rather depend, interact with, and react to the adjacent microenvironment. Melanoma is composed of not only the malignant cells but also the supporting stroma, which includes fibroblasts, endothelial cells, immune cells, soluble molecules, and the extracellular matrix (ECM). Tumor cells actively interact with the microenvironment in a bidirectional manner through molecular signals that modulate the malignant phenotype. This article briefly reviews the molecular basis of melanomagenesis as well as the interplay of melanoma with other cells of the tumor microenvironment and components of the ECM. It also discusses the influence of the microenvironment on therapeutic targeting of melanoma, highlighting recent studies that propose novel strategies to target tumor-microenvironment interactions.
Conflict of interest statement
Disclosures
No potential conflicts of interest relevant to this article were reported.
Similar articles
-
Role of matrix metalloproteinases in melanoma cell invasion.Biochimie. 2005 Mar-Apr;87(3-4):307-14. doi: 10.1016/j.biochi.2005.01.013. Biochimie. 2005. PMID: 15781317 Review.
-
[Tumor-stroma interactions].Bull Cancer. 2008 Jan;95(1):51-6. doi: 10.1684/bdc.2008.0560. Bull Cancer. 2008. PMID: 18230570 Review. French.
-
Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy.Int J Mol Sci. 2021 Jan 7;22(2):529. doi: 10.3390/ijms22020529. Int J Mol Sci. 2021. PMID: 33430277 Free PMC article. Review.
-
Stromal reaction in cutaneous melanoma.Crit Rev Oncol Hematol. 2004 Mar;49(3):269-75. doi: 10.1016/j.critrevonc.2003.10.007. Crit Rev Oncol Hematol. 2004. PMID: 15036266 Review.
-
Remodeling of the microenvironment by aggressive melanoma tumor cells.Ann N Y Acad Sci. 2003 May;995:151-61. doi: 10.1111/j.1749-6632.2003.tb03218.x. Ann N Y Acad Sci. 2003. PMID: 12814947 Review.
Cited by
-
Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironment.Histochem Cell Biol. 2010 Jan;133(1):113-24. doi: 10.1007/s00418-009-0654-5. Epub 2009 Oct 21. Histochem Cell Biol. 2010. PMID: 19844737
-
The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma.Front Oncol. 2022 Jan 21;11:811434. doi: 10.3389/fonc.2021.811434. eCollection 2021. Front Oncol. 2022. PMID: 35127523 Free PMC article. Review.
-
Extracellular Vesicles Derived from Acidified Metastatic Melanoma Cells Stimulate Growth, Migration, and Stemness of Normal Keratinocytes.Biomedicines. 2022 Mar 12;10(3):660. doi: 10.3390/biomedicines10030660. Biomedicines. 2022. PMID: 35327461 Free PMC article.
-
High-Plex Spatial RNA Profiling Reveals Cell Type‒Specific Biomarker Expression during Melanoma Development.J Invest Dermatol. 2022 May;142(5):1401-1412.e20. doi: 10.1016/j.jid.2021.06.041. Epub 2021 Oct 23. J Invest Dermatol. 2022. PMID: 34699906 Free PMC article.
-
Cytokines in the microenvironment of Waldenström's macroglobulinemia.Clin Lymphoma Myeloma. 2009 Mar;9(1):43-5. doi: 10.3816/CLM.2009.n.010. Clin Lymphoma Myeloma. 2009. PMID: 19362970 Free PMC article. Review.
References
-
- Tawbi HA, Kirkwood JM. Management of metastatic melanoma. Semin Oncol. 2007;34:532–545. Review of current treatments for metastatic melanoma with special emphasis in chemotherapeutic agents. - PubMed
-
- Smalley KS, Lioni M, Noma K, et al. In vitro three-dimensional tumor microenvironment models for anticancer drug discovery. Expert Opin Drug Discov. 2008;3:1–10. - PubMed
-
- Haass NK, Smalley KS, Li L, et al. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 2005;18:150–159. - PubMed
-
- Meier F, Schittek B, Busch S, et al. The RAS/RAF/MEK/ ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front Biosci. 2005;10:2986–3001. - PubMed
-
- Li G, Fukunaga M, Herlyn M. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling. Exp Cell Res. 2004;297:142–151. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical